Alberto Toso

Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) Enhancing chemotherapy efficacy by reprogramming the senescence-associated secretory phenotype of prostate tumors: A way to reactivate the antitumor immunity

OncoImmunology, 22 gennaio 2015

2) Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity

Cell Reports, 9 ottobre 2014

3) Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer

Nature, 6 novembre 2014

Facts & figures

Alberto Toso has coordinated or participated in 3 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) whose subjects can be represented by this 8 elements tag cloud:

chemotherapy (2) prostate tumors (2) cancer (1) immune system (1) myeloid cells (1) PTEN (1) SASP (1) senescence (1)

Alberto Toso has coordinated or participated in 3 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) featured by 3 scientific journals:

Cell Reports (1) Nature (1) OncoImmunology (1)

Alberto Toso has coordinated or participated in 3 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) involving also 18 co-authors being active in Ticino:

Diletta Di Mitri (3) Andrea Alimonti (3) Sandra Pinton (2) Erica Montani (2) Carlo Catapano (2) Ramon Garcia-Escudero (2) Manuela Sarti (2) Ilaria Guccini (2) Fabio Grassi (2) Rocco D’Antuono (1) Michele Proietti (1) Madhuri Kalathur (1) Gianluca Civenni (1) Ajinkya Revandkar (1) Tanja Rezzonico Jost (1) Jing Jing Chen (1) David Jarrossay (1) Camilla Marini (1)

Alberto Toso has coordinated or participated in 3 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) in whose synopsis the 16 most frequently used terms (excluding 12 not relevant terms) are here listed:

A.T. WORD CLOUD chemotherapy (2) senescence-associated (2) prostate (2) tumors (2) antitumor (2) secretory (1) phenotype (1) reactivate (1) pten-deficient (1) activating (1) tumour-infiltrating (1) gr (1) myeloid (1) antagonize (1) senescence (1) cancer (1)

In the synopsis of the whole 3332 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations), the 197 most frequently used terms (excluding 12 not relevant or unfrequently used terms (terms used less than 10 times) are here listed:

THE WHOLE WORD CLOUD cancer (299) covid- (186) thyroid (111) pet (109) cardiac (107) prostate (107) sars-cov- (103) hiv (89) atrial (81) breast (81) coronary (79) sclerosis (76) fibrillation (69) lymphoma (68) pandemic (67) bone (54) aortic (52) heart (51) artery (51) stroke (50) liver (47) carcinoma (46) brain (44) antibodies (42) cardiovascular (41) lung (40) mri (39) transcatheter (36) metastatic (35) dna (35) ventricular (35) kidney (34) nodules (34) tumor (33) extracellular (33) virus (33) myocardial (32) knee (31) ultrasound (30) oncology (30) mitral (27) antibody (27) esmo (27) percutaneous (26) f-fdg (26) hepatitis (25) vesicles (25) spinal (25) antiplatelet (24) cervical (24) ischemic (24) osteoarthritis (23) tuberculosis (23) diabetes (23) infarction (23) chemotherapy (23) ovarian (22) sentinel (22) radiotherapy (22) bladder (22) pulmonary (22) sperm (22) ehra (22) endovascular (21) implantation (21) transplantation (21) vaccination (21) renal (21) blood (20) lymph (19) resonance (19) plasma (19) tomography (19) urinary (19) bacterial (19) b-cell (18) monoclonal (18) nuclear (18) tumors (18) pacing (18) fdg (17) colorectal (17) laparoscopic (17) mice (17) implantable (16) autoimmune (16) vaccine (16) transplant (16) coronavirus (16) immunodeficiency (16) radiomics (15) membrane (15) preclinical (15) metabolic (15) metabolism (15) vascular (15) musculoskeletal (15) tricuspid (14) endometrial (14) pneumonia (14) antiretroviral (14) biomarker (14) serum (14) mrna (14) metastasis (14) lymphomas (14) fractures (14) peripheral (14) neurocognitive (14) leukemia (14) occlusion (13) male (13) behavior (13) muscle (13) interventions (13) legs (13) radiation (13) arterial (13) hemorrhage (13) nerve (13) biomarkers (13) pregnancy (13) lymphocytic (13) medullary (12) malignant (12) platelet-rich (12) hiv- (12) metastases (12) tau (12) iga (12) conference (12) mutations (12) malignancy (12) brugada (12) joint (12) fna (12) grafts (12) ischemia (12) dementia (12) esc (12) radiology (11) baseline (11) gastric (11) intravenous (11) arrhythmia (11) dynamic (11) incontinence (11) burden (11) pi (11) contemporary (11) contrast-enhanced (11) pathways (11) adherence (11) catheter (11) parkinson (11) limb (11) cytology (11) signaling (11) neck (11) mesenchymal (11) senescence (11) lockdown (11) il- (11) administration (10) overview (10) regurgitation (10) depression (10) art (10) idiopathic (10) clonal (10) bayesian (10) checkpoint (10) antithrombotic (10) precision (10) recovery (10) possible (10) prognosis (10) cancers (10) vascularized (10) adapted (10) peptide (10) ecg (10) infectious (10) fixation (10) prolapse (10) pci (10) hip (10) migraine (10) skin (10) prophylaxis (10) follicular (10) igg (10) vitamin (10) epidemiology (10) lipid (10) refractory (10) anesthesia (10)

Alberto Toso has coordinated or participated in the 3 publications here listed (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations)

1) Enhancing chemotherapy efficacy by reprogramming the senescence-associated secretory phenotype of prostate tumors: A way to reactivate the antitumor immunity

2) Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity

3) Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer

Alberto Toso has coordinated or participated in the 3 publications here listed
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations)